Zdroje

Použitá literatúra a citácie


  1. Weintraub D, Comella CL, Horn S. Parkinson's disease-Part 1: Pathophysiology, symptoms, burden, diagnosis and assessment. Am J Manag Care 2008; 14 (2 Suppl): S40–48.
  2. Poewe W, Mahlknecht P. The clinical progression of Parkinson's disease. Parkinsonism Relat Disord 2009; 15 (Suppl 4): S28–S32.
  3. Chaudhuri KR, Ondo W. Handbook of Movement Disorders. London: Current Medicine Group, 2009.
  4. Goldman JG, Postuma R. Premotor and nonmotor features of Parkinson’s disease. Curr Opin Neurol 2014; 27 (4): 434–441.
  5. Kalia LV, Lang AE. Parkinson’s disease. Lancet 2015; 386 (9996): 896–912.
  6. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159): 1789–1858.
  7. Chahine, L. M., A. W. Amara and A. Videnovic (2017). "A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015." Sleep Med Rev 35: 33-50.
  8. Varanese, S., Z. Birnbaum, R. Rossi and A. Di Rocco (2011). "Treatment of advanced Parkinson's disease." Parkinsons Dis 2010: 480260.
  9. Schrag, A., M. Jahanshahi and N. Quinn (2000). "How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population." Mov Disord 15(6): 1112-1118.
  10. Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13. PMID: 28332488.
  11. Hawkins, R. A., R. L. O'Kane, I. A. Simpson, and J. R. Viña, 2006, Structure of the blood-brain barrier and its role in the transport of amino acids: J Nutr, v. 136, p. 218S-26S